IBDEI0YW ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15756,1,4,0)
 ;;=4^B35.3
 ;;^UTILITY(U,$J,358.3,15756,2)
 ;;=^119732
 ;;^UTILITY(U,$J,358.3,15757,0)
 ;;=B35.5^^61^765^322
 ;;^UTILITY(U,$J,358.3,15757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15757,1,3,0)
 ;;=3^Tinea Imbricata
 ;;^UTILITY(U,$J,358.3,15757,1,4,0)
 ;;=4^B35.5
 ;;^UTILITY(U,$J,358.3,15757,2)
 ;;=^119725
 ;;^UTILITY(U,$J,358.3,15758,0)
 ;;=B35.4^^61^765^320
 ;;^UTILITY(U,$J,358.3,15758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15758,1,3,0)
 ;;=3^Tinea Corporis
 ;;^UTILITY(U,$J,358.3,15758,1,4,0)
 ;;=4^B35.4
 ;;^UTILITY(U,$J,358.3,15758,2)
 ;;=^119704
 ;;^UTILITY(U,$J,358.3,15759,0)
 ;;=B35.8^^61^765^140
 ;;^UTILITY(U,$J,358.3,15759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15759,1,3,0)
 ;;=3^Dermatophytoses,Other
 ;;^UTILITY(U,$J,358.3,15759,1,4,0)
 ;;=4^B35.8
 ;;^UTILITY(U,$J,358.3,15759,2)
 ;;=^5000606
 ;;^UTILITY(U,$J,358.3,15760,0)
 ;;=B36.9^^61^765^312
 ;;^UTILITY(U,$J,358.3,15760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15760,1,3,0)
 ;;=3^Superficial Mycosis,Unspec
 ;;^UTILITY(U,$J,358.3,15760,1,4,0)
 ;;=4^B36.9
 ;;^UTILITY(U,$J,358.3,15760,2)
 ;;=^5000611
 ;;^UTILITY(U,$J,358.3,15761,0)
 ;;=D69.0^^61^765^33
 ;;^UTILITY(U,$J,358.3,15761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15761,1,3,0)
 ;;=3^Allergic Purpura
 ;;^UTILITY(U,$J,358.3,15761,1,4,0)
 ;;=4^D69.0
 ;;^UTILITY(U,$J,358.3,15761,2)
 ;;=^5002365
 ;;^UTILITY(U,$J,358.3,15762,0)
 ;;=B00.9^^61^765^161
 ;;^UTILITY(U,$J,358.3,15762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15762,1,3,0)
 ;;=3^Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,15762,1,4,0)
 ;;=4^B00.9
 ;;^UTILITY(U,$J,358.3,15762,2)
 ;;=^5000480
 ;;^UTILITY(U,$J,358.3,15763,0)
 ;;=B02.9^^61^765^331
 ;;^UTILITY(U,$J,358.3,15763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15763,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,15763,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,15763,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,15764,0)
 ;;=D17.9^^61^765^90
 ;;^UTILITY(U,$J,358.3,15764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15764,1,3,0)
 ;;=3^Benign Lipomatous Neop,Unspec
 ;;^UTILITY(U,$J,358.3,15764,1,4,0)
 ;;=4^D17.9
 ;;^UTILITY(U,$J,358.3,15764,2)
 ;;=^5002020
 ;;^UTILITY(U,$J,358.3,15765,0)
 ;;=E08.621^^61^765^137
 ;;^UTILITY(U,$J,358.3,15765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15765,1,3,0)
 ;;=3^DM d/t Underlying Condition w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,15765,1,4,0)
 ;;=4^E08.621
 ;;^UTILITY(U,$J,358.3,15765,2)
 ;;=^5002534
 ;;^UTILITY(U,$J,358.3,15766,0)
 ;;=E09.621^^61^765^136
 ;;^UTILITY(U,$J,358.3,15766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15766,1,3,0)
 ;;=3^DM d/t Drug/Chemical w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,15766,1,4,0)
 ;;=4^E09.621
 ;;^UTILITY(U,$J,358.3,15766,2)
 ;;=^5002576
 ;;^UTILITY(U,$J,358.3,15767,0)
 ;;=H05.011^^61^765^112
 ;;^UTILITY(U,$J,358.3,15767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15767,1,3,0)
 ;;=3^Cellulitis of Right Orbit
 ;;^UTILITY(U,$J,358.3,15767,1,4,0)
 ;;=4^H05.011
 ;;^UTILITY(U,$J,358.3,15767,2)
 ;;=^5004560
 ;;^UTILITY(U,$J,358.3,15768,0)
 ;;=H05.012^^61^765^105
 ;;^UTILITY(U,$J,358.3,15768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15768,1,3,0)
 ;;=3^Cellulitis of Left Orbit
 ;;^UTILITY(U,$J,358.3,15768,1,4,0)
 ;;=4^H05.012
 ;;^UTILITY(U,$J,358.3,15768,2)
 ;;=^5004561
 ;;^UTILITY(U,$J,358.3,15769,0)
 ;;=H05.013^^61^765^99
 ;;^UTILITY(U,$J,358.3,15769,1,0)
 ;;=^358.31IA^4^2
